ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript August 7, 2023
ReShape Lifesciences Inc. beats earnings expectations. Reported EPS is $-0.00108, expectations were $-1.79.
Operator: Good afternoon, and thank you for joining the ReShape Lifesciences Second Quarter 2023 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications.
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences second quarter 2023...
